Active · per the CBE, 17 November 2026

CoraVix Solutions

BE1023167678

Rechtspersoon Private limited company 1 establishment

CoraVix Solutions is a testing and inspection body in Bierbeek. Private Limited, started on 9 May 2025, 1 establishment.

Bloesemlaan 29/C, 3360 Bierbeek

Active for

1 year, 6 months

Financials

Financial year 2025

CoraVix Solutions from Bierbeek, company number BE1023167678, closed financial year 2025 with a result of € 3,673 after tax. For that financial year CoraVix Solutions recorded a gross margin of € 5,206 and equity of € 8,673. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Healthy

€ 8,673

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 3,673

Profit after tax over the fiscal year.

Cash in the bank

€ 12,362

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 3,673.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 446

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 6,888

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

What happened to CoraVix Solutions?

What happened at CoraVix Solutions in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 3,673. Source: NBB ↗
  • Incorporation, published in the Gazette. Source: Staatsblad ↗
  • New establishment in Bierbeek. KBO

In short

Paid € 1,575 in corporate taxes since 2025.

Establishments

Establishment units

Physical locations of this company

Registered office

Bloesemlaan 29/C

3360 Bierbeek

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Flemish Brabant

Same main activity (Overige technische testen en toetsen), 155 active companies in Flemish Brabant, largest first.

VINCOTTE

€ 136.1 million revenue · 2025 · Vilvoorde

Laboratoire belge de l'Industrie Electrique

€ 106.1 million revenue · 2025 · Linkebeek

VINÇOTTE

€ 76.2 million revenue · 2025 · Vilvoorde

ACEG

€ 38.5 million revenue · 2025 · Grimbergen

Algemene Certificaten voor Elektriciteit & Gas

€ 26.7 million revenue · 2025 · Grimbergen

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

Source: Deed ↗
  • Gheorghe-Corneliu TOMOIAGA(oprichter) 50%
  • Alina-Maria TOMOIAGA(oprichter) 50%

Details

Company number
1023.167.678
VAT number
BE 1023.167.678
Registered office
Bloesemlaan 29/C, 3360 Bierbeek
Names & denominations
CoraVix Solutions
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
9 May 2025
Peppol
Active · Active since 15 Dec 2025
Activities · NACE

Overige technische testen en toetsen

Frequently asked questions

What does CoraVix Solutions do?
CoraVix Solutions is a testing and inspection body in Bierbeek. Private Limited, started on 9 May 2025, 1 establishment.
What is the address of CoraVix Solutions?
The registered office of CoraVix Solutions is located at Bloesemlaan 29/C, 3360 Bierbeek.
Is CoraVix Solutions still active?
Yes. According to the CBE (17 November 2026) CoraVix Solutions is active, legal situation “Normale toestand”, started on 9 May 2025.
Is CoraVix Solutions registered on Peppol?
Yes, CoraVix Solutions is registered on the Peppol network with ID 0208:1023167678.
What is the enterprise number of CoraVix Solutions?
The enterprise number of CoraVix Solutions is BE1023167678.
When was CoraVix Solutions founded?
CoraVix Solutions was founded on 9 May 2025.